Oncotarget Plasma Growth Hormone in HCC: A Biomarker of Response to Atezo/Bev? In a new study, researchers investigated the plasma growth hormone as a potential biomarker of... read more December 8, 2022
Oncotarget Downregulation of Gene Found as Prognostic Biomarker of HCC A genome-wide analysis of DNA methylation concluded that the TBX15 gene is hypermethylated and downregulated... read more December 29, 2020